Galmed Pharmaceuticals Ltd. (GLMD)
NASDAQ: GLMD · Real-Time Price · USD
0.5400
+0.0100 (1.89%)
At close: Apr 2, 2026, 4:00 PM EDT
0.5500
+0.0100 (1.85%)
After-hours: Apr 2, 2026, 6:43 PM EDT
Galmed Pharmaceuticals Market Cap
Galmed Pharmaceuticals has a market cap or net worth of $3.55 million as of April 2, 2026. Its market cap has decreased by -6.47% in one year.
Market Cap
3.55M
Enterprise Value
-14.54M
1-Year Change
-6.47%
Ranking
Category
Stock Price
$0.54
Market Cap Chart
Since March 13, 2014, Galmed Pharmaceuticals's market cap has decreased from $145.70M to $3.55M, a decrease of -97.56%. That is a compound annual growth rate of -26.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 1, 2026 | 3.50M | -14.63% |
| Dec 31, 2025 | 4.10M | -14.58% |
| Dec 31, 2024 | 4.80M | 166.67% |
| Dec 29, 2023 | 1.80M | -85.71% |
| Dec 30, 2022 | 12.60M | -72.43% |
| Dec 31, 2021 | 45.70M | -30.44% |
| Dec 31, 2020 | 65.70M | -45.93% |
| Dec 31, 2019 | 121.50M | 23.23% |
| Dec 31, 2018 | 98.60M | -11.33% |
| Dec 29, 2017 | 111.20M | 185.13% |
| Dec 30, 2016 | 39.00M | -53.85% |
| Dec 31, 2015 | 84.50M | 42.98% |
| Dec 31, 2014 | 59.10M | -59.44% |
| Mar 13, 2014 | 145.70M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silexion Therapeutics | 3.93M |
| Alzamend Neuro | 3.88M |
| Indaptus Therapeutics | 3.88M |
| VivoSim Labs | 3.69M |
| GeoVax Labs | 3.60M |
| Azitra | 3.53M |
| Matinas BioPharma Holdings | 3.52M |
| Decoy Therapeutics | 3.46M |